Keyphrases
Hepatocellular Carcinoma
100%
Cytoreductive Surgery
100%
Hepatobiliary Malignancy
100%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
100%
Gallbladder
75%
Cholangiocarcinoma
75%
Peritoneal Carcinomatosis
75%
Overall Survival
50%
Malignancy
50%
Pancreaticobiliary
50%
Hepatopancreaticobiliary
50%
Progression-free Survival
25%
Postoperative Outcomes
25%
Survival Benefit
25%
Current Therapies
25%
30-day Mortality
25%
Adjuvant Therapy
25%
Neoadjuvant Therapy
25%
Oncological Outcomes
25%
Poor Survival
25%
Systemic Chemotherapy
25%
Hepatocellular Carcinoma Patients
25%
Index numbers
25%
Sorafenib
25%
Peritoneal Cancer Index
25%
Pancreatic Malignancy
25%
Completeness of Cytoreduction
25%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Cytoreductive Surgery
100%
Hepatobiliary Cancer
100%
Hyperthermic Intraperitoneal Chemotherapy
100%
Cancer
60%
Cholangiocarcinoma
60%
Carcinomatous Peritonitis
60%
Overall Survival
40%
Progression Free Survival
20%
Neoadjuvant Therapy
20%
Adjuvant Therapy
20%
Sorafenib
20%
Peritoneum Cancer
20%